Pharmacokinetics and Pharmacodynamics of Antifungals
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 20 (3) , 679-697
- https://doi.org/10.1016/j.idc.2006.06.007
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole andCandida albicansAntimicrobial Agents and Chemotherapy, 2006
- Voriconazole Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2006
- Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic OutcomeAntimicrobial Agents and Chemotherapy, 2006
- International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- In Vitro Interactions between Amphotericin B, Itraconazole, and Flucytosine against 21 Clinical Aspergillus Isolates Determined by Two Drug Interaction ModelsAntimicrobial Agents and Chemotherapy, 2004
- Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Pharmacodynamics of Amphotericin B in a Neutropenic-Mouse Disseminated-Candidiasis ModelAntimicrobial Agents and Chemotherapy, 2001
- Evaluation of the E test for fluconazole susceptibility testing ofCandida albicans isolates from oropharyngeal candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Correlation between antifungal susceptibility testing ofCandida isolates from patients with HIV infection and clinical results after treatment with fluconazoleInfection, 1994
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979